CoChat

Antiemetic use of olanzapine in patients with advanced cancer: results from an open-label multicenter study.

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Introduction The antipsychotic drug olanzapine is effective against chemotherapy-induced nausea and targets multiple receptors known to be involved in the emetic reflex arch. The drug has a mean half-life of 30 h, which allows for a single daily administration and is therefore of interest in patients with advanced cancer suffering from nausea. Objectives To investigate the antiemetic effect and tolerability of olanzapine in patients with advanced cancer not receiving chemotherapy or irradiation. Methods Patients with advanced cancer (no curable treatment options) with at least "moderate" nausea and/or one emetic episode within the last 24 h were included if they had not received chemotherapy or irradiation (last 2 weeks) and had no reversible causes of nausea/vomiting. Patients were administered 10 mg olanzapine daily for 5 days (the first day subcutaneously and the following 4 days orally). Nausea, vomiting, and adverse effects were assessed daily for 7 days. The primary efficacy parameter was nausea after 24 h. Results Forty patients from four centers were included and all evaluable after 24 h. Thirty-six patients experienced some degree of improvement. The mean two-item N/V score (0-100) at baseline was 66 and improved to 21 and 24 after 24 h and 7 days, respectively. During the course of the study, the dose of olanzapine was reduced in three patients due to adverse events. Five patients were withdrawn from the study primarily due to progression of malignant disease or per…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00520-018-4593-3

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Research works printed but not linked: 2

  1. Shinjo T, Okada M (2006) Olanzapine use in cancer patients for refractory vomiting. Gan To Kagaku Ryoho 33(3):349–352
  2. Dev R (2018) Intractable nausea and anorexia with weight loss in a patient with advanced breast cancer. J Cachexia Sarcopenia Muscle 9(1):203

Cited by

See all 17

Metadata

Authors
Harder, S., Groenvold, M., Isaksen, J., Sigaard, J., Frandsen, K. B., Neergaard, M. A., Mondrup, L., & Herrstedt, J.
Affiliations
  • University of Southern Denmark (DK)
  • Odense University Hospital (DK)
  • Hospital South West Jutland (DK)
  • Frederiksberg Hospital (DK)
  • Aarhus University Hospital (DK)
  • University of Copenhagen (DK)
Corresponding author
Harder, Signe
Venue
Supportive Care in Cancer
Published
2018-12-14
Volume
27
Issue
8
Pages
2849-2856
ISSN
  • 0941-4355 (ISSN-L)
  • 1433-7339
OpenAlex
W2904007992
Cited by
17
References
31
Citations by year
2026: 1 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 1
FWCI
2.08
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Supportive Care in Cancer (publishedVersion)
  • PubMed (publishedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
  • Kræftens Bekæmpelse (R56-A3126)
  • IMK foundation (None)
  • Odense Universitetshospital (None)
Topics
  • Health Sciences › Medicine › Surgery › Nausea and vomiting management
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative and Oncologic Care
Keywords
olanzapine, antiemetic effect, nausea, vomiting, advanced cancer, antipsychotic drugs, emetic reflex, tolerability, adverse effects
MeSH terms
Olanzapine, Adult, Aged, Antiemetics, Female, Humans, Male, Middle Aged, Nausea, Neoplasms, Antipsychotic Agents, Vomiting

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antiemetic use of olanzapine in patients with advanced cancer: results from an open-label multicenter study. https://app.cochat.ai/papers/10.1007/s00520-018-4593-3
The paper
Harder, S., Groenvold, M., Isaksen, J., Sigaard, J., Frandsen, K. B., Neergaard, M. A., Mondrup, L., & Herrstedt, J. (2019). Antiemetic use of olanzapine in patients with advanced cancer: results from an open-label multicenter study. Supportive Care in Cancer. https://doi.org/10.1007/s00520-018-4593-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.